English: If I deal with the last question first, because I think, actually, if people go to a testing centre with a range of symptoms that aren't classical, but they can explain how they feel, then most people are not going to be turned away. That isn't going to be the experience. And, actually, our bigger problem is that there are people who have symptoms but don't get a test. If you look at the technical advisory group reports that we have continued to publish every week, you'll see there's a regular feature in there, and one of the regular features that I certainly look at every week, even if others don't, is you look at the number of people who acknowledge they've had symptoms and then how many of them go on to have a test, and only about half of the people who have the classic symptoms, as was put in the question, actually go on to get themselves tested. So, there is a real issue there, and there's a divide in age ranges, and a divide between genders as well. Men, frankly, are much less likely to get tested, and, actually, we know that older men are one of the higher risk categories as well. So, it's really frustrating. We need to get the message out: if you've got the symptoms, get yourself a test. And there is plenty of testing capacity at this point in time, because - one of your earlier points was that the lockdowns have worked in driving down transmission rates. Transmission rates are falling, case rates are falling - we want to see that continue - and that means that fewer people are going to get tests. And in terms of the genomic expertise that we do have, we punch well above our weight here in Wales, and we should be really proud of what our genomic experts are delivering in terms of the overall effort, not just to Wales, the UK, but the wider world as well. The labs we have currently are in a position where we're able to pick up a range of new variants. We've had agreement about making sure that we have a representative sample of Welsh tests to go to lighthouse labs so they can pick up the new UK variant, the Kent variant. And we also have a range of testing in place to pick up where we might have the South African variant. That's why - . We have low numbers of the South African variant here - literally handfuls - as opposed to the much larger numbers that, unfortunately, have tested positive in England. And it'll be really important for us - we want that testing programme in England looking for the South African variant to succeed, because that will actually help to keep all of us safe as well. And some of the areas where they're testing are on the Welsh border, so it's really important that we keep close to each other across the UK to understand the knowledge that we're each acquiring, and then to share it openly. And that has been a really important feature in this pandemic. It will have to carry on for many months ahead into the future.
Welsh: Os caf i ymdrin â'r cwestiwn olaf yn gyntaf, oherwydd rwy'n credu, mewn gwirionedd, os bydd pobl yn mynd i ganolfan brofi gydag ystod o symptomau nad ydyn nhw'n rhai arferol, ond yn gallu egluro sut maen nhw'n teimlo, yna ni fydd y rhan fwyaf o bobl yn cael eu gwrthod. Nid dyna fydd eu profiad nhw. Ac, mewn gwirionedd, y broblem fwyaf sydd gennym yw'r bobl sydd â symptomau ond nad ydyn nhw'n cael eu profi. Os edrychwch chi ar adroddiadau'r grŵp cynghori technegol yr ydym ni'n parhau i'w cyhoeddi bob wythnos, fe welwch chi fod nodwedd reolaidd yn y rhain, ac un o'r nodweddion rheolaidd yr wyf i'n sicr yn edrych arno bob wythnos, hyd yn oed os nad yw eraill yn gwneud hynny, yw edrych ar nifer y bobl sy'n cydnabod eu bod nhw wedi bod â symptomau ac yna faint ohonyn nhw sy'n mynd ymlaen i gael y prawf, a dim ond tua hanner y bobl sydd â'r symptomau arferol, fel y mynegwyd yn y cwestiwn, sy'n mynd ymlaen i gael eu prawf eu hunain. Felly, mae problem wirioneddol yma, ac mae yna raniad mewn ystod oedran a rhaniad rhwng y rhywiau hefyd. A dweud y gwir, mae dynion yn llawer llai tebygol o fynd am brawf, ac, mewn gwirionedd, fe wyddom ni mai dynion hŷn yw un o'r categorïau risg uwch hefyd. Felly, mae hyn yn achosi rhwystredigaeth fawr. Mae angen inni gyhoeddi'r neges: os oes gennych chi symptomau, ewch am brawf. Ac mae digon o adnoddau profi ar gael ar hyn o bryd, oherwydd - un o'ch pwyntiau cynharach chi oedd bod y cyfyngiadau symud wedi gweithio o ran gostwng cyfraddau trosglwyddo. Mae'r cyfraddau trosglwyddo yn gostwng, mae cyfraddau achosion yn gostwng - rydym yn dymuno gweld hynny'n parhau - ac mae hynny'n golygu y bydd llai o bobl yn cael profion. Ac o ran yr arbenigedd sydd gennym o ran genomeg, rydym yn cyflawni llawer mwy na'r disgwyl yng Nghymru, ac fe ddylem fod yn falch iawn o'r hyn y mae ein harbenigwyr genomeg yn ei gyflawni o ran yr ymdrech gyffredinol, nid yn unig ar gyfer Cymru, a'r DU, ond yn fyd-eang hefyd. Mae'r labordai sydd gennym ni ar hyn o bryd mewn sefyllfa i allu darganfod amrywiaeth o amrywiolion newydd. Rydym ni wedi cytuno i sicrhau y bydd gennym ni sampl gynrychioliadol o brofion o Gymru i'w hanfon i labordai goleudy fel y gallan nhw ddarganfod amrywiolyn newydd y DU, amrywiolyn Caint. Ac mae gennym amrywiaeth o brofion ar waith hefyd i ddarganfod ymhle y gallem fod ag amrywiolyn De Affrica. Dyna pam - . Niferoedd isel o amrywiolyn De Affrica sydd gennym ni yma - dyrnaid yn llythrennol - yn hytrach na'r niferoedd llawer mwy sydd, yn anffodus, wedi eu profi yn gadarnhaol yn Lloegr. Ac fe fydd hyn yn bwysig iawn i ni - rydym yn awyddus i weld llwyddiant gyda'r rhaglen brofi honno yn Lloegr sy'n chwilio am amrywiolyn De Affrica, oherwydd fe fydd honno mewn gwirionedd yn helpu i gadw pob un ohonom yn ddiogel. Ac mae rhai o'r ardaloedd lle maen nhw'n cynnal profion ar y ffin â Chymru, felly mae'n bwysig iawn ein bod ni'n cadw'n agos at ein gilydd ledled y DU er mwyn deall yr wybodaeth yr ydym yn ei chaffael, a'i rhannu'n agored wedyn. Ac mae honno wedi bod yn nodwedd bwysig iawn drwy gydol y pandemig hwn. Fe fydd yn rhaid i hynny barhau am fisoedd lawer i ddod.